The ImproveCareNow Registry: Prediction of different remission rates in pediatric ulcerative colitis
Abstract Objectives Identifying predictors of clinical remission in pediatric ulcerative colitis (UC) will impact the therapeutic approach. We aimed to predict time to first (TFR), corticosteroid‐free (TCSFR, ≥3 months corticosteroid withdrawal), and sustained remission (TSR, ≥6 months).
Jonathan Van Hecke +7 more
wiley +1 more source
Negotiating Medication Adherence in Everyday Life with Inflammatory Bowel Disease: A Qualitative Study. [PDF]
Ljungström E +3 more
europepmc +1 more source
Abstract Commercial payers and pharmacy benefit managers use site‐of‐care and specialty drug distribution policies (including white bagging and brown bagging) that can redirect infusion‐based biologic therapies from hospital outpatient departments to alternate settings.
Brad Pasternak
wiley +1 more source
Early transmural response assessed by intestinal ultrasound predicts long-term clinical remission in patients with IBD: Results from the TRUST BEYOND study. [PDF]
Kucharzik T +9 more
europepmc +1 more source
Abstract Accurate pediatric gastrointestinal (GI) diagnosis often depends on integrating clinical, endoscopic, and histopathologic information. We evaluated the impact of weekly face‐to‐face multidisciplinary team (MDT) meetings on diagnosis in children undergoing endoscopy or liver biopsy at a tertiary center.
Emma Dahl +4 more
wiley +1 more source
Using a Person-Centred Approach to Adapt a Digital Therapy for Inflammatory Bowel Disease (COMPASS-IBD). [PDF]
Harding S +8 more
europepmc +1 more source
Insurance IQ: Demystifying health insurance for young people with inflammatory bowel disease
ABSTRACT Many adolescents and young adults with inflammatory bowel disease (AYA‐IBD) lack essential health insurance knowledge. We evaluated an electronic health record (EHR)–based educational intervention to improve insurance literacy. From January to August 2025, AYA‐IBD who had completed a health insurance knowledge assessment and had an upcoming ...
Laura Gilligan, Jeannie S. Huang
wiley +1 more source
Protease-serpin-microbiome interactions in inflammatory bowel disease: toward integrated biomarkers of gut health. [PDF]
Almalki M +12 more
europepmc +1 more source
Abstract BACKGROUND Ulcerative colitis (UC) is a relapsing inflammatory bowel disease characterised by oxidative stress, inflammation and regulated cell death of the colonic mucosa. Because live probiotics may cause bacteraemia and sepsis in immunocompromised hosts, non‐viable (paraprobiotic) alternatives have attracted interest.
Adem Yavaş, Ezgi Özkıran, Ecem Akan
wiley +1 more source
Gut microbiota-derived metabolites target C5AR1/KDM2A/HCAR3 axis in inflammatory bowel disease: a multi-machine learning algorithms and molecular docking study. [PDF]
Hu S, Fu L, Gao J, Guo Q, Han S.
europepmc +1 more source

